Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.33 AUD | -4.51% | -4.12% | -19.38% |
Mar. 05 | Australia shares inch lower as miners weigh; GDP data in focus | RE |
Feb. 28 | Australian Clinical Labs Falls 11% After Trimming Interim Dividend on Lower H1 FY24 EPS | MT |
Sales 2024 * | 683M 455M | Sales 2025 * | 711M 474M | Capitalization | 489M 326M |
---|---|---|---|---|---|
Net income 2024 * | 29M 19.32M | Net income 2025 * | 38M 25.32M | EV / Sales 2024 * | 0.77 x |
Net Debt 2024 * | 39.25M 26.15M | Net Debt 2025 * | 17.81M 11.87M | EV / Sales 2025 * | 0.71 x |
P/E ratio 2024 * |
17.1
x | P/E ratio 2025 * |
12.6
x | Employees | 5,115 |
Yield 2024 * |
3.52% | Yield 2025 * |
4.65% | Free-Float | 55.76% |
Latest transcript on Australian Clinical Labs Limited
1 day | -4.51% | ||
1 week | -4.12% | ||
Current month | -4.12% | ||
1 month | -3.32% | ||
3 months | -20.21% | ||
6 months | -12.08% | ||
Current year | -19.38% |
Managers | Title | Age | Since |
---|---|---|---|
Melinda McGrath
CEO | Chief Executive Officer | - | 14-12-31 |
James Davison
DFI | Director of Finance/CFO | - | 14-12-31 |
Tony Landgren
CTO | Chief Tech/Sci/R&D Officer | - | 08-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Alscher
CHM | Chairman | 56 | 14-12-31 |
Leanne Rowe
BRD | Director/Board Member | 67 | 21-04-27 |
Director/Board Member | - | 23-08-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 2 M€ | -.--% | ||
0.01% | 7 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 2.33 | -4.51% | 1 467 635 |
24-05-16 | 2.44 | -0.41% | 886,395 |
24-05-15 | 2.45 | -3.92% | 788,887 |
24-05-14 | 2.55 | +3.24% | 250,309 |
24-05-13 | 2.47 | +1.65% | 296,583 |
Delayed Quote Australian S.E., May 17, 2024 at 12:50 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.38% | 327M | |
+19.22% | 84.52B | |
-27.14% | 72.21B | |
+4.65% | 27.74B | |
-6.23% | 17.97B | |
+1.60% | 17.46B | |
+3.30% | 15.82B | |
+7.44% | 13.55B | |
+9.91% | 13.31B | |
+73.32% | 13.32B |
- Stock Market
- Equities
- ACL Stock